Effect of propolis as an adjuvant treatment of Helicobacter pylori

Evaluation of cyclodextrin and propolis complex as adjuvant treatment in patients with Helicobacter pylori

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230503058065N1

Enrollment

100

Registered

2024-01-22

Start date

2024-02-04

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Pylori infection.

Interventions

Intervention group:.

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with symptoms of dyspepsia Helicobacter pylori patients with a positive biopsy test

Exclusion criteria

Exclusion criteria: People with duodenal gastrointestinal bleeding Pregnant women Breastfeeding women Patients with liver disorders Patients with renal failure Patients with heart failure Patients with a history of drug sensitivity to any of the studied drugs Patients who have previously been treated with Helicobacter pylori therapy Patients taking NSAIDs Patients who are taking corticosteroids Patients with a history of alcohol consumption

Design outcomes

Primary

Measure	Time frame
Improvement of digestive symptoms. Timepoint: 60 days after the start of the intervention. Method of measurement: Questionnaire and fecal antigen test.	—

Secondary

Measure	Time frame
Helicobacter pylori eradication. Timepoint: 60 days after the start of the intervention. Method of measurement: Fecal antigen test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAisa Mehri

Hamedan University of Medical Sciences

Aisaamehrii@gmail.com+98 81 3832 5546

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026